RestorLife Med Review
RestorLife Med is no longer available as we reviewed it, so this page is kept for reference.
RestorLife Med: Website has been taken down and is not taking patients. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →RestorLife Med was a physician-led telehealth practice that prescribed compounded semaglutide and tirzepatide, including microdose plans. Its website has been taken down: the address now returns a hosting error, so there is no way to sign up, refill or check current prices.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to RestorLife Med
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
RestorLife Med at a glance
- Type
- GLP-1 telehealth provider
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored RestorLife Med
Each dimension is scored algorithmically from RestorLife Med’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.8/10RestorLife Med no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
7.2/10RestorLife Med's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence, so weigh the clinical support carefully.
User Experience15%
8.6/10Online intake and platform experience; 2 platform features disclosed.
Trust & Safety15%
9.5/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
10.0/10RestorLife Med treats patients in all 50 states.
Support10%
7.6/10RestorLife Med provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this RestorLife Med review
Last checked October 2026- Confirmed availability in all 50 states
- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What we like
- Review page kept live so former patients get a straight answer
Watch-outs
- Website has been taken down, so there is no way to sign up or reorder
- No published notice explains the outage or where patients should go
Is RestorLife Med still an option?
RestorLife Med no longer offers a GLP-1 weight-loss program, so there is nothing to sign up for today. We cannot quote a current price, because none exists. We keep this page online so past users can see what it offered and find a program that still operates.
If you were a RestorLife Med patient, talk with your prescriber before your remaining supply runs out. That keeps treatment going without a gap or an unsafe restart dose. Then compare current providers on price, medication and state coverage, starting with the alternatives below.
The Bottom Line
RestorLife Med is no longer available as we reviewed it, so this page is kept for reference.
RestorLife Med might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this RestorLife Med review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.